Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-8-16
|
pubmed:abstractText |
IL-1 beta is a cytokine generally considered to be a major component involved in the pathogenesis of rheumatoid arthritis and other inflammatory diseases. Of the agents found in high concentrations in inflamed rheumatoid arthritis joints, TNF-alpha is among the most strongly implicated as an in vivo inducer of IL-1 beta. Here we report that in human PBMC and in a stable transfectant of the promonocytic cell line, THP-1, TNF-alpha indeed appears to be an inducer of IL-1 beta production, but only in the presence of dibutyryl cAMP or agents such as the PG that elevate intracellular cAMP levels. This TNF-alpha/cAMP pathway regulates IL-1 beta production at the level of transcription and requires a cAMP response element located between -2762 and -2755 bp in the upstream regulatory sequence of IL-1 beta. Because PG, which are known to elevate cAMP levels in vivo, and TNF-alpha are both found in significant quantities in the synovial fluid of rheumatoid arthritis joints, the observed synergistic up-regulation in IL-1 beta synthesis by TNF-alpha/cAMP (PG) may provide valuable insight into the potential pathways involved in the continuous production of IL-1 beta in the chronically inflamed joint.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Bucladesine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
155
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
836-44
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7608561-Alkaline Phosphatase,
pubmed-meshheading:7608561-Base Sequence,
pubmed-meshheading:7608561-Bucladesine,
pubmed-meshheading:7608561-Cell Line,
pubmed-meshheading:7608561-Cyclic AMP,
pubmed-meshheading:7608561-Enzyme Induction,
pubmed-meshheading:7608561-Humans,
pubmed-meshheading:7608561-Interleukin-1,
pubmed-meshheading:7608561-Isoenzymes,
pubmed-meshheading:7608561-Molecular Sequence Data,
pubmed-meshheading:7608561-Monocytes,
pubmed-meshheading:7608561-Placenta,
pubmed-meshheading:7608561-Signal Transduction,
pubmed-meshheading:7608561-Transcription, Genetic,
pubmed-meshheading:7608561-Tumor Necrosis Factor-alpha
|
pubmed:year |
1995
|
pubmed:articleTitle |
A cyclic adenosine 3',5'-monophosphate signal is required for the induction of IL-1 beta by TNF-alpha in human monocytes.
|
pubmed:affiliation |
Department of Cell Physiology, Glaxo Wellcome, Inc., Research Triangle Park, NC 27709, USA.
|
pubmed:publicationType |
Journal Article
|